#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Transfusion and Haematology Today / 2014 - 4

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

Czech version

Published in: Transfuze Hematol. dnes,20, 2014, No. 4, p. 106.
Category: Selection of press reports and books

Labels
Haematology Internal medicine Clinical oncology
Pharmacokinetics as a tool for optimising the treatment of patients with haemophilia
The significance of heavy/light chain immunoglobulin pairs (Hevylite™) in multiple myeloma
Retransfusion system with integrated double filtration – parameters of product quality
Activity of Blood Transfusion Service in the Czech Republic 1989–2013
Quality indicators of the Czech National Marrow Donors Registry for 2013 and comparisons with previous years
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
Factors that predict thrombosis in relatives of patients with venous thromboembolism
Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation
Article was published in

Transfusion and Haematology Today

Issue 4
2014 Issue 4
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#